Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study
Jifeng Feng, Liang Wang, Xun Yang, Qixun Chen · 2024
Read Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study by Jifeng Feng, Liang Wang, Xun Yang, Qixun Chen (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11685212.txt.
Description
Jifeng Feng and three colleagues ask whether extra immune therapy after surgery helps patients with a cancer of the food pipe, in a 2024 study. All patients had drug treatment before surgery and then had the tumor removed.
The team reviewed records for 215 patients treated in 2019 and 2020. Overall, those who got the extra therapy lived no longer without the disease returning than those who did not. One group did gain: patients whose removed tissue still held tumor in both the pipe wall and nearby nodes. For them, the extra therapy cut the risk of return and death. The authors call for a randomized trial to confirm the finding.
Catalog record
| CREATOR | Jifeng Feng, Liang Wang, Xun Yang, Qixun Chen |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |